Teijin Swings to Nine-Month Loss but Keeps Dividend and Full-Year Guidance Intact

Teijin ( (JP:3401) ) has shared an announcement.

Teijin reported a sharp deterioration in results for the nine months to December 31, 2025, with revenue down 12.7% year on year to ¥659.9 billion and adjusted operating income slipping 7.0% to ¥23.8 billion, while operating income and profit before tax plunged into deep losses of ¥53.8 billion and ¥55.9 billion respectively. The company swung from a prior-year profit attributable to owners of the parent of ¥51.0 billion to a loss of ¥59.0 billion, translating into a basic loss per share of ¥305.81 and contributing to a decline in equity attributable to owners of the parent from ¥431.4 billion to ¥387.1 billion and a lower equity ratio of 39.1%. Despite this financial strain, Teijin kept its dividend stance intact, having already paid an interim ¥25 per share and maintaining a full-year dividend forecast of ¥50, while leaving its full-year FY2025 guidance unchanged at ¥860.0 billion in revenue, ¥25.0 billion in adjusted operating income, and a modest ¥5.0 billion in operating income, implying management’s expectation of some recovery in the final quarter even as a full-year net loss of ¥10.0 billion is still projected.

The most recent analyst rating on (JP:3401) stock is a Hold with a Yen1607.00 price target. To see the full list of analyst forecasts on Teijin stock, see the JP:3401 Stock Forecast page.

More about Teijin

Teijin Limited is a Tokyo-listed diversified manufacturer operating under IFRS, with core businesses spanning advanced materials and healthcare-related products, and is a constituent of Japan’s Prime Market aimed at global institutional and retail investors.

Average Trading Volume: 934,131

Technical Sentiment Signal: Buy

Current Market Cap: Yen287.1B

Find detailed analytics on 3401 stock on TipRanks’ Stock Analysis page.